suvorexant 450.92100 PMID:25291725 Reaxys:18339082 MK4305 KEGG:D10082 PMID:24680372 PMID:24550770 InChI=1S/C23H23ClN6O2/c1-15-3-5-20(30-25-8-9-26-30)18(13-15)22(31)29-12-11-28(10-7-16(29)2)23-27-19-14-17(24)4-6-21(19)32-23/h3-6,8-9,13-14,16H,7,10-12H2,1-2H3/t16-/m1/s1 chebi_ontology PMID:23692283 An aromatic amide obtained by formal condensation of the carboxy group of 5-methyl-2-(2H-1,2,3-triazol-2-yl)benzoic acid with the secondary amino group of 5-chloro-2-[(5R)-5-methyl-1,4-diazepan-1-yl]-1,3-benzoxazole. An orexin receptor antagonist used for the management of insomnia. CAS:1030377-33-3 MK 4305 Drug_Central:4881 PMID:23372274 PMID:25299902 JYTNQNCOQXFQPK-MRXNPFEDSA-N 0 [(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone C23H23ClN6O2 PMID:25227290 Wikipedia:Suvorexant MK-4305 PMID:25231363 450.15710 C[C@@H]1CCN(CCN1C(=O)c1cc(C)ccc1-n1nccn1)c1nc2cc(Cl)ccc2o1 CHEBI:82698 PMID:25167596 BELSOMRA PMID:24368893 PMID:25197807 PMID:24488306 PMID:24757363 molecular pathway modifying agent therapy